These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35921214)
1. Long-Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis-Specific Autoantibodies: A Single Cohort Study. Jiang W; Shi J; Yang H; Tian X; Yang H; Chen Q; Zhang L; Peng Q; Wang G; Lu X Arthritis Care Res (Hoboken); 2023 May; 75(5):1175-1182. PubMed ID: 35921214 [TBL] [Abstract][Full Text] [Related]
2. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China. Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245 [TBL] [Abstract][Full Text] [Related]
3. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort. Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X Front Immunol; 2022; 13():879266. PubMed ID: 35603153 [TBL] [Abstract][Full Text] [Related]
4. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review. Teel A; Lu J; Park J; Singh N; Basharat P Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345 [TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809 [TBL] [Abstract][Full Text] [Related]
7. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy. Weng CT; Huang TH; Wu CH; Sun YT Arthritis Res Ther; 2024 Aug; 26(1):152. PubMed ID: 39175076 [TBL] [Abstract][Full Text] [Related]
8. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis. Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322 [TBL] [Abstract][Full Text] [Related]
9. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome. Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X Front Immunol; 2022; 13():845988. PubMed ID: 35320936 [TBL] [Abstract][Full Text] [Related]
10. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies. Wong VT; So H; Lam TT; Yip RM Acta Neurol Scand; 2021 Feb; 143(2):131-139. PubMed ID: 32762037 [TBL] [Abstract][Full Text] [Related]
11. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease. Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366 [TBL] [Abstract][Full Text] [Related]
12. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study. Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164 [TBL] [Abstract][Full Text] [Related]
18. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive. Fang X; Zou L; Zhao H; Liu B Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996 [TBL] [Abstract][Full Text] [Related]